Clinical Trial Update: Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Fasting Conditions [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the relative bioavailability of Ribavirin 200 capsules versus Rebetol 200 mg capsules in fasting female participants. The investigation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Rebetol (ribavirin)
• Ribavirin (ribavirin)

Snippet

Sponsor: Sandoz | Conditions: Chronic Hepatitis C | Phase 1 | Status: COMPLETED